home / stock / cemi / cemi news


CEMI News and Press, Chembio Diagnostics Inc. From 11/16/21

Stock Information

Company Name: Chembio Diagnostics Inc.
Stock Symbol: CEMI
Market: NASDAQ
Website: chembio.com

Menu

CEMI CEMI Quote CEMI Short CEMI News CEMI Articles CEMI Message Board
Get CEMI Alerts

News, Short Squeeze, Breakout and More Instantly...

CEMI - Chembio Diagnostics Submits EUA Application for New DPP SARS-CoV-2 Antigen Test

HAUPPAUGE, N.Y., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced the submission of an Emergency Use Authorization (EUA) application to the U.S. Food and Drug Administ...

CEMI - Chembio Diagnostics Announces Extension of Delivery Schedule for Bio Manguinhos Purchase Order of DPP SARS-COV-2 Antigen Tests

HAUPPAUGE, N.Y., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (“Chembio”) (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced that the delivery schedule for shipments of DPP SARS-COV-2 Antigen Tests under i...

CEMI - Chembio Diagnostics, Inc. (CEMI) CEO Richard Eberly on Q2 2021 Results - Earnings Call Transcript

Chembio Diagnostics, Inc. (CEMI) Q3 2021 Earnings Conference Call November 04, 2021 04:30 PM ET Company Participants Richard Eberly - President & Chief Executive Officer Neil Goldman - Executive Vice President & Chief Financial Officer Conference Call Participants Bruce Jackson - The ...

CEMI - Chembio Diagnostics Reports Third Quarter 2021 Financial Results

HAUPPAUGE, N.Y., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (“Chembio” or the “Company”) (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial results for the quarter ended September ...

CEMI - Chembio Diagnostics to Report Third Quarter 2021 Financial Results on November 4, 2021

HAUPPAUGE, N.Y., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial results for the third quarter of 2021 after the close of trading on Thursda...

CEMI - Chembio Announces EUA Submission for DPP Respiratory Antigen Panel

HAUPPAUGE, N.Y., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced the submission of an Emergency Use Authorization (EUA) application to the Food and Drug Administrati...

CEMI - CEI, CEMI and CBIO among pre market gainers

IVERIC bio (NASDAQ:ISEE) +65% Apellis' mixed eye-drug data turns out to be 'positive' for Iveric Bio Vince Holding (NYSE:VNCE) +22% on Q2 earnings. Affirm Holdings (NASDAQ:AFRM) +21% on Q4 earnings. Endo International (NASDAQ:ENDP) +18% settles New York state opi...

CEMI - Investing in Penny Stocks in September? 3 Strategies to Know

3 Must-Know Strategies For Buying Penny Stocks in September Buying penny stocks right now is unlike any other time in the past few years. While investors are more or less used to the pandemic and its effects on the market, there are several other factors that traders need to take into c...

CEMI - Hot Penny Stocks to Buy This Month? 3 to Watch Now

3 Penny Stocks For Your Watchlist in September After a rather volatile week of trading penny stocks, investors are looking forward to a new month in the market. And while a new month is not a complete paradigm shift, it does present a clean slate to see some potential bullish action. Ri...

CEMI - "The Buzz" Show: Chembio Diagnostics, Inc. (NYSE: CEMI) Distribution of Third-Party COVID-19 Test

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Chembio Diagnostics, Inc. Launches Commercial Distribution of Third-Party COVID-19 Antigen Test” Chembio Diagnostics, Inc. (NYSE: CEMI) climbed over 13% in premark...

Previous 10 Next 10